Pinyol et al. identified the molecular specificity of NASH-HCC, with the TERT promoter, CTNNB1, TP53, and ACVR2A as the most commonly mutated genes. This evidence concerns the gene ACVR2A and metabolic dysfunction-associated steatohepatitis.